Donglei Yu

2.1k total citations
49 papers, 1.8k citations indexed

About

Donglei Yu is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Donglei Yu has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Infectious Diseases and 15 papers in Organic Chemistry. Recurrent topics in Donglei Yu's work include HIV/AIDS drug development and treatment (16 papers), Natural product bioactivities and synthesis (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Donglei Yu is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Natural product bioactivities and synthesis (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Donglei Yu collaborates with scholars based in United States, China and Taiwan. Donglei Yu's co-authors include Kuo‐Hsiung Lee, Susan L. Morris‐Natschke, Lan Xie, Madoka Suzuki, Chin‐Ho Chen, Li Huang, Fang‐Rong Chang, Graham P. Allaway, Arnold Brossi and Jingjing Yu and has published in prestigious journals such as Advanced Materials, Journal of Medicinal Chemistry and Industrial & Engineering Chemistry Research.

In The Last Decade

Donglei Yu

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donglei Yu United States 21 747 592 332 185 163 49 1.8k
Xiaojie Jin China 22 346 0.5× 766 1.3× 199 0.6× 178 1.0× 59 0.4× 87 1.6k
Maria Grishina Russia 23 761 1.0× 459 0.8× 74 0.2× 78 0.4× 85 0.5× 124 1.8k
Ahmad J. Obaidullah Saudi Arabia 27 737 1.0× 690 1.2× 86 0.3× 80 0.4× 77 0.5× 151 2.0k
Chuanjun Song China 25 863 1.2× 846 1.4× 82 0.2× 472 2.6× 86 0.5× 115 2.2k
Charles B. de Koning South Africa 32 2.8k 3.8× 783 1.3× 247 0.7× 134 0.7× 70 0.4× 133 3.3k
L. M. Viranga Tillekeratne United States 19 359 0.5× 481 0.8× 123 0.4× 113 0.6× 87 0.5× 80 1.2k
Arabinda Ghosh India 26 265 0.4× 724 1.2× 140 0.4× 212 1.1× 110 0.7× 106 1.9k
Sarfraz Ahmed Pakistan 18 232 0.3× 320 0.5× 156 0.5× 130 0.7× 41 0.3× 80 1.5k
Van V. Vu Vietnam 22 241 0.3× 917 1.5× 132 0.4× 399 2.2× 144 0.9× 50 2.0k
Wannian Zhang China 26 2.2k 3.0× 1.2k 2.0× 413 1.2× 123 0.7× 416 2.6× 62 3.4k

Countries citing papers authored by Donglei Yu

Since Specialization
Citations

This map shows the geographic impact of Donglei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglei Yu more than expected).

Fields of papers citing papers by Donglei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglei Yu. The network helps show where Donglei Yu may publish in the future.

Co-authorship network of co-authors of Donglei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Donglei Yu. A scholar is included among the top collaborators of Donglei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglei Yu. Donglei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yu, Donglei, Zhizhang Yuan, & Xianfeng Li. (2023). Enhanced stability of nickel cathode for nickel-based batteries by electroless nickel phosphide plating. Chemical Engineering Science. 270. 118512–118512. 5 indexed citations
3.
Yu, Donglei, Muhammad Khalid Anser, Abdelmohsen A. Nassani, et al.. (2023). Navigating the global mineral market: A study of resource wealth and the energy transition. Resources Policy. 82. 103500–103500. 57 indexed citations
4.
Yu, Donglei, Feifei Zhang, Yang Song, et al.. (2022). Scalable Alkaline Zinc‐Iron/Nickel Hybrid Flow Battery with Energy Density up to 200 Wh L −1. Advanced Materials. 35(7). e2209390–e2209390. 18 indexed citations
7.
Tang, Jian, Keduo Qian, Ying Chen, et al.. (2010). Anti-AIDS agents 82: Synthesis of seco-(3′R,4′R)-3′,4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) derivatives as novel anti-HIV agents. Bioorganic & Medicinal Chemistry. 18(12). 4363–4373. 17 indexed citations
8.
Huang, Li, Donglei Yu, Phong Ho, et al.. (2008). Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives. Bioorganic & Medicinal Chemistry. 16(14). 6696–6701. 24 indexed citations
9.
Lee, Chia-Lin, Kyoko Nakagawa‐Goto, Donglei Yu, et al.. (2008). Cytotoxic calanquinone A from Calanthe arisanensis and its first total synthesis. Bioorganic & Medicinal Chemistry Letters. 18(15). 4275–4277. 18 indexed citations
10.
Yu, Jingjing, Donglei Yu, Tian Zhao, & Baizhao Zeng. (2007). Development of amperometric glucose biosensor through immobilizing enzyme in a Pt nanoparticles/mesoporous carbon matrix. Talanta. 74(5). 1586–1591. 100 indexed citations
11.
Qian, Keduo, Kyoko Nakagawa‐Goto, Donglei Yu, et al.. (2007). Anti-AIDS agents 73: Structure–activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(23). 6553–6557. 29 indexed citations
12.
Fukamiya, Narihiko, Donglei Yu, Tzu-Hsuan Chen, et al.. (2006). Tripfordines A−C, Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii, and Structure Anti-HIV Activity Relationships of Tripterygium Alkaloids.. Journal of Natural Products. 70(1). 142–142.
13.
Huang, Li, et al.. (2005). Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives. Virology. 332(2). 623–628. 66 indexed citations
14.
Yu, Donglei, Carl Wild, David E. Martin, et al.. (2005). The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV. Expert Opinion on Investigational Drugs. 14(6). 681–693. 41 indexed citations
15.
Xie, Lan, et al.. (2005). Molecular modeling, design, synthesis, and biological evaluation of novel 3′,4′-dicamphanoyl-(+)-cis-khellactone (DCK) analogs as potent anti-HIV agents. Bioorganic & Medicinal Chemistry. 13(23). 6435–6449. 10 indexed citations
16.
Zhang, Qian, Ying Chen, Peng Xia, et al.. (2004). Anti-AIDS agents. Part 62: Anti-HIV activity of 2′-substituted 4-methyl-3′,4′-di-O-(−)-camphanoyl-(+)-cis-khellactone (4-methyl DCK) analogs. Bioorganic & Medicinal Chemistry Letters. 14(23). 5855–5857. 15 indexed citations
17.
Wu, Jiu-Hong, Fang‐Rong Chang, Ken‐ichiro Hayashi, et al.. (2003). Antitumor agents. Part 218: Cappamensin A, a new In vitro anticancer principle, from Capparis sikkimensis. Bioorganic & Medicinal Chemistry Letters. 13(13). 2223–2225. 35 indexed citations
18.
Yu, Donglei, Arnold Brossi, Nicole Kilgore, et al.. (2003). Anti-HIV Agents. Part 55: 3′R,4′R-Di-(O)-(−)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP), a Novel Anti-HIV agent. Bioorganic & Medicinal Chemistry Letters. 13(9). 1575–1576. 42 indexed citations
19.
Yu, Donglei, Madoka Suzuki, Lan Xie, Susan L. Morris‐Natschke, & Kuo‐Hsiung Lee. (2003). Recent progress in the development of coumarin derivatives as potent anti‐HIV agents. Medicinal Research Reviews. 23(3). 322–345. 442 indexed citations
20.
Yu, Donglei, et al.. (2001). Annonaceous Acetogenins of the Seeds fromAnnona Muricata. Journal of Asian Natural Products Research. 3(4). 267–276. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026